ESN364
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ESN364, covering 2021-09-29 to 2024-10-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ESN364 in Healthy Japanese Male and Pre- and Post-menopausal Female Subjects [Phase 1]